Goodheart MJ - Search Results

1

Prediction of chemo-response in serous ovarian cancer.

Gonzalez Bosquet J, Newtson AM, Chung RK, Thiel KW, Ginader T, Goodheart MJ, Leslie KK, Smith BJ. Gonzalez Bosquet J, et al. Among authors: goodheart mj. Mol Cancer. 2016 Oct 19;15(1):66. doi: 10.1186/s12943-016-0548-9. Mol Cancer. 2016. PMID: 27756408 Free PMC article.

2

p21 expression predicts outcome in p53-null ovarian carcinoma.

Rose SL, Goodheart MJ, DeYoung BR, Smith BJ, Buller RE. Rose SL, et al. Among authors: goodheart mj. Clin Cancer Res. 2003 Mar;9(3):1028-32. Clin Cancer Res. 2003. PMID: 12631602

3

The influence of microvessel density on ovarian carcinogenesis.

Stone PJ, Goodheart MJ, Rose SL, Smith BJ, DeYoung BR, Buller RE. Stone PJ, et al. Among authors: goodheart mj. Gynecol Oncol. 2003 Sep;90(3):566-71. doi: 10.1016/s0090-8258(03)00367-6. Gynecol Oncol. 2003. PMID: 13678725

4

The impact of p53 protein core domain structural alteration on ovarian cancer survival.

Rose SL, Robertson AD, Goodheart MJ, Smith BJ, DeYoung BR, Buller RE. Rose SL, et al. Among authors: goodheart mj. Clin Cancer Res. 2003 Sep 15;9(11):4139-44. Clin Cancer Res. 2003. PMID: 14519637

5

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

Geisler JP, Goodheart MJ, Sood AK, Holmes RJ, Hatterman-Zogg MA, Buller RE. Geisler JP, et al. Among authors: goodheart mj. Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770. Cancer. 2003. PMID: 14601090 Free article.

6

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.

Jacobson GM, Kamath RS, Smith BJ, Goodheart MJ. Jacobson GM, et al. Among authors: goodheart mj. Gynecol Oncol. 2005 Feb;96(2):470-4. doi: 10.1016/j.ygyno.2004.10.023. Gynecol Oncol. 2005. PMID: 15661237

7

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer.

Goodheart MJ, Ritchie JM, Rose SL, Fruehauf JP, De Young BR, Buller RE. Goodheart MJ, et al. Clin Cancer Res. 2005 May 15;11(10):3733-42. doi: 10.1158/1078-0432.CCR-04-0056. Clin Cancer Res. 2005. PMID: 15897570

8

Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.

Goodheart M, Jacobson G, Smith BJ, Zhou L. Goodheart M, et al. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):95-103. doi: 10.1111/j.1525-1438.2007.00967.x. Epub 2007 Apr 26. Int J Gynecol Cancer. 2008. PMID: 17466049

9

BRCA2 alteration is important in clear cell carcinoma of the ovary.

Goodheart MJ, Rose SL, Hattermann-Zogg M, Smith BJ, De Young BR, Buller RE. Goodheart MJ, et al. Clin Genet. 2009 Aug;76(2):161-7. doi: 10.1111/j.1399-0004.2009.01207.x. Epub 2009 Jul 28. Clin Genet. 2009. PMID: 19656163

10

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S, Leslie KK. Devor EJ, et al. Among authors: goodheart mj. Oncol Rep. 2011 Oct;26(4):995-1002. doi: 10.3892/or.2011.1372. Epub 2011 Jul 1. Oncol Rep. 2011. PMID: 21725615 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page